Nieves Dana-Farber taking a first stab at tackling the issue of safety of IO in pts with autoimmune disease in #RCC. Important clinical question! Lauren Harshman Anis Hamid Toni Choueiri, MD Bradley McGregor @AminNassar92 Xiao Wei, MD

Great CR of 18% with Ipi/Nivo with sarcomatoid histology in CM 214 by Nizar Tannir #KCA2018

Outstanding presentation by Cristiane D Bergerot about QoL - psychosocial factors as a key predictor of survival in #RCC patients #KCA18

Awed by what David Braun is doing with single cells and fruit 🍉. So much more to come. #cathywu #wulab Dana-Farber Toni Choueiri, MD

Just the start of many great things Nieves . "You got this" and YOLO. We will miss you in Boston.

#IKCS18: Tony Finelli gives a touching introduction, and review of an outstanding career, for Michael Jewett for the Novick award - congrats! Lauren Harshman Brian Shuch, MD

Amazing research makes us VERY excited going into 2019 that we will have continued to improve care.Opening ARS question at #IKCS2018 I hope meeting helped stimulate ideas and collaboration.Kidney Cancer Lauren Harshman Sumanta K. Pal, MD, FASCO Toni Choueiri, MD Deb Maskens

.Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute presents our exciting data w Toni Choueiri, MD Ulka Vaishampayan on cabo-atezo; 80% RR in ccRCC & exceptional tolerability. Excited to see this move forward in other cohorts, including #bladdercancer, #HCC, #NSCLC & many more! goo.gl/1E3gUb

Plz take a moment & go to asco.org & vote in the 2019 ASCO elections. #kidneycancer expert from Cleveland Clinic MD, CancerDotNet editor & all-around fantastic person Brian Rini, MD running for Nominating Cmte. Toni Choueiri, MD Uromigos et al let’s mobilize the GU community!

Lauren Harshman Aly-Khan Lalani Fabio Schutz Dominick Bossé, MD MPH Ziad Bakouny, MD, MSc Petros Grivas Uromigos Maxine Sun

Fantastic commentary from Petros Grivas Fred Hutchinson Cancer Center University of Washington (clincancerres.aacrjournals.org/content/early/…) on paper from Kent Mouw Eli Van Allen et al (ncbi.nlm.nih.gov/pubmed/29980530) in AACR journal CCR

Indeed I do James! For all these reasons we should support studies testing neoadjuvant anti PD1 priming in RCC and other cancers #PROSPERRCC Mohamad Allaf Michael Staehler Daniel Heng Deb Maskens Viraj Master Brian Shuch, MD ECOG-ACRIN Cancer Research Group

It's not too late to donate to Movember and support this important cause! #Bellissimo Atish Choudhury, MD PhD led a great effort for the Boston crew this year but it doesn't have to be just one month long Mark Preston Lorelei Mucci Toni Choueiri, MD Rick Lee 이재방 Christopher Sweeney, MBBS @steinharterjack

Fantastic effort by Nieves & #LaureHirsh and many great colleagues. Can't wait to see what you two rising stars do next for patients and the field!

Please join captain Misha Beltran & #TeamBellissimo for our Movember USA grand finale party Kings Dining & Ent. Boston Back Bay on 11/30/21, details below⬇️ PCF Science Howard Soule Brigham and Women's Hospital Department of Urology Brigham and Women’s Radiation Oncology Lorelei Mucci Rick Lee 이재방 Adam Feldman Mark Preston Lauren Harshman Paul Nguyen

#Kidneycancerawareness #InternationalWomansDay Thank you to all the Women in RCC moving us forward! Tian Zhang, MD, MHS Ulka Vaishampayan Cristiane D Bergerot @ElizamackMD Lisa Henske @SarahkaMD Shilpa Gupta Arpita Desai Kimryn Rathmell Katy Beckermann Nazli Dizman Laurence Albiges Rana McKay, MD, FASCO

Congratulations Lorelei and ACS!

We planned this Special Clinical Science Symposium on the promise of neoadjuvant IO for #ASCO23 and couldn’t be more excited about the speakers and abstracts!

Thanks for getting this to the finish line Atish Choudhury, MD PhD! With much appreciation to the patients, study teams, and colleagues who made it happen and those there when it all began Phil Kantoff Prostate Cancer Foundation

With ASTRO elections coming up this week, why do so many members think Neha Vapiwala deserves our vote to be the next President? For starters, former ASTRO presidents and gold medal winners have concurred she is one of the most inclusive and effective leaders to ever run for